First-in-human implantation of bionic device to halt Crohn’s disease
The device, developed and manufactured by the Bionics Institute in collaboration with researchers at The Florey and The University of Melbourne, could put Crohn’s sufferers into long-term remission.
Crohn’s disease is a condition that causes inflammation to the lining of the gut. Most patients with Crohn’s eventually require bowel surgery to remove sections of gut damaged by inflammation. However, the disease frequently returns, requiring further surgery.
Co-investigator and team leader Professor John Furness, head of The Florey’s Digestive Physiology and Nutrition Laboratories, said this breakthrough therapy could transform the lives of people suffering from Crohn’s disease.
“By stimulating anti-inflammatory nerves and addressing inflammation early, the recurrent inflammation and associated scar tissue development can hopefully be prevented altogether, meaning patients will avoid the cycle of surgery and recovery.”
Associate Professor Peter De Cruz, Austin Health’s Director of Inflammatory Bowel Disease Service said Crohn’s disease can have significant impacts on the lives of Australians throughout some of the best years of their lives.
